Position in CRVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,731,007
+$3,832,724 QoQ
Shares Held
785,208
+45.4% QoQ
Ownership
0.933%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#21
of 172 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,624,947 across 342 Biotechnology names. CRVS ranks #79 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in CRVS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,731,007 | 785,208 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,898,283 | 539,869 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,105,704 | 143,598 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,498,763 | 203,360 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $895,652 | 223,913 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $980,553 | 308,350 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $162,126 | 30,304 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $377,794 | 71,552 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $86,970 | 47,786 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $182,359 | 102,449 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $318,039 | 180,704 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $398,590 | 273,007 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $582,241 | 254,254 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $185,682 | 204,047 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $239,008 | 281,187 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $351,930 | 429,708 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $357,423 | 361,034 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $826,814 | 504,155 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,242,377 | 930,447 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $679,802 | 140,455 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $826,773 | 309,653 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,074,168 | 348,756 | Shares | Sole | 2021-05-17 | |
| 2020-06-30 | $138,110 | 50,776 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $209,434 | 99,258 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||